Elad Sharon (S Elad)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 72

Top Topics

Tyrosine Kinase

Metastatic Colorectal Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer 130 (17) (2024)
Kellie Alleyne-Mike, John Glod, Erissa Cuffie, Rajiv Kissoon, Bernard Bedaysie, Pearse Sylvester, Matthew Boron, J Michelle Brockman, Nancy Moore, Alice P Chen, Elad Sharon
Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago. JCO global oncology 10 (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer (2024)
Kellie Alleyne-Mike, John Glod, Erissa Cuffie, Rajiv Kissoon, Bernard Bedaysie, Pearse Sylvester, Matthew Boron, J Michelle Brockman, Nancy Moore, Alice P Chen, Elad Sharon
Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago. JCO global oncology 10 (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer 130 (17) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Kellie Alleyne-Mike, John Glod, Erissa Cuffie, Rajiv Kissoon, Bernard Bedaysie, Pearse Sylvester, Matthew Boron, J Michelle Brockman, Nancy Moore, Alice P Chen, Elad Sharon
Perspective: The COVID-19 Pandemic: Closing Borders, Opening Doors, and Breaking Ground on the Potential for Clinical Trial Access in Developing Countries Like Trinidad and Tobago. JCO global oncology 10 (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Kara M Schenk, Julie Stein Deutsch, Sunandana Chandra, Diwakar Davar, Zeynep Eroglu, Nikhil I Khushalani, Jason John Luke, Patrick A Ott, Jeffrey A Sosman, Vikram Aggarwal, Megan D Schollenberger, William H Sharfman, Kristin P Bibee, Jeffrey F Scott, Manisha J Loss, Hao Wang, Hanfei Qi, Elad Sharon, Howard Streicher, Helen X Chen, Robert N Woodward, Serena M Bagnasco, Janis M Taube, Suzanne L Topalian, Daniel C Brennan, Evan J Lipson
Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Jack Gallifant, Leo Anthony Celi, Elad Sharon, Danielle S Bitterman
Navigating the Complexities of Artificial Intelligence-Enabled Real-World Data Collection for Oncology Pharmacovigilance. JCO clinical cancer informatics 8 (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer 130 (17) (2024)
Sandip Pravin Patel, Elizabeth Guadarrama, Young Kwang Chae, Michael J Dennis, Benjamin C Powers, Chih-Yi Liao, William A Ferri, Thomas J George, Elad Sharon, Christopher W Ryan, Megan Othus, Gabby Lopez, Charles D Blanke, Razelle Kurzrock
SWOG 1609 cohort 48: anti-CTLA-4 and anti-PD-1 for advanced gallbladder cancer. Cancer (2024)
Andrea B Apolo, Daniel M Girardi, Scot A Niglio, Rosa Nadal Rios, Andre R Kydd, Nicholas Simon, Lisa Ley, Lisa M Cordes, Elias B A Chandran, Seth M Steinberg, Sunmin Lee, Min-Jung Lee, Shraddha Rastogi, Nahoko Sato, Liang Cao, A Rouf Banday, Salah Boudjadi, Maria J Merino, Antoun Toubaji, Dilara Akbulut, Bernadette Redd, Hadi Bagheri, Rene Costello, Sandeep Gurram, Piyush K Agarwal, Heather J Chalfin, Vladimir Valera, Howard Streicher, John Joseph Wright, Elad Sharon, William Douglas Figg, Howard L Parnes, James L Gulley, Biren Saraiya, Sumanta Kumar Pal, David I Quinn, Mark N Stein, Primo N Lara, Donald P Bottaro, Amir Mortazavi
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (25) (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Caitriona Cahir, Xin Victoria Wang, David M Hyman, Petros D Grivas, Edith P Mitchell, John J Wright, Elad Sharon, Robert C Gray, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jue Wang, Kari B Wisinski, James V Tricoli, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Peter J O'Dwyer, Helen X Chen, Keith T Flaherty
Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey S Weber, Laura C Cappelli
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology. Journal for immunotherapy of cancer 11 (3) (2023)
Nadia Howlader, Elad Sharon, Manami Bhattacharya, Lori A Ehrlich, Nicholas C Richardson, Nicole J Gormley, R Angelo de Claro, Amy E Wood, Angela B Smith, Kathleen A Cronin
The Impact of Improved Treatments on Survival of Adult US Leukemia Patients: 1990 - 2018. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Ari M VanderWalde, Shay L Bellasea, Kari L Kendra, Nikhil I Khushalani, Katie M Campbell, Philip O Scumpia, Lawrence F Kuklinski, Frances Collichio, Jeffrey A Sosman, Alexandra P Ikeguchi, Adrienne I Victor, Thach-Giao Truong, Bartosz Chmielowski, David C Portnoy, Yuanbin Chen, Kim A Margolin, Charles Bane, Constantin A Dasanu, Douglas B Johnson, Zeynep Eroglu, Sunandana Chandra, Egmidio Medina, Cynthia R Gonzalez, Ignacio Baselga-Carretero, Agustin Vega-Crespo, Ivan Perez Garcilazo, Elad Sharon, Siwen Hu-Lieskovan, Sapna Pradyuman Patel, Kenneth F Grossmann, James Moon, Michael C Wu, Antoni Ribas
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial. Nature medicine (2023)
Harriet M Kluger, Hussein A Tawbi, David Feltquate, Theresa LaVallee, Naiyer A Rizvi, Elad Sharon, Jeffrey Sosman, Ryan J Sullivan
Society for Immunotherapy of Cancer (SITC) checkpoint inhibitor resistance definitions: efforts to harmonize terminology and accelerate immuno-oncology drug development. Journal for immunotherapy of cancer 11 (7) (2023)
Elad Sharon, Megan Othus, Zoe Eloise Quandt
Signal detection in real-world data and confirmation in clinical trials: Diabetes as a case study for a conversation worth having. Cancer (2023)
Thomas A Odeny, Kathryn Lurain, Julius Strauss, Steven P Fling, Elad Sharon, Anna Wright, Javier Martinez-Picado, Teresa Morán, James L Gulley, Maria Gonzales Cao, Thomas S Uldrick, Robert Yarchoan, Ramya Ramaswami
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer. Journal for immunotherapy of cancer 10 (9) (2023)
Laura E Hogan, Patrick A Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Teena Bhatla, Michael J Borowitz, Elizabeth A Raetz, Andrew J Carroll, Nyla A Heerema, Gerhard Zugmaier, Elad Sharon, Melanie Brooke Bernhardt, Stephanie A Terezakis, Lia Gore, James A Whitlock, Stephen P Hunger, Mignon L Loh
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Amin H Nassar, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingjia Li, Arjun Mittra, Dwight H Owen, Robert A Baiocchi, Michael Lorentsen, Christopher Dittus, Nazli Dizman, Adewunmi Falohun, Noha Abdel-Wahab, Adi Diab, Anand Bankapur, Alexandra Reed, Chul Kim, Aakriti Arora, Neil J Shah, Edward El-Am, Elie Kozaily, Wassim Abdallah, Ahmad Al-Hader, Batool Abu Ghazal, Anwaar Saeed, Claire Drolen, Melissa G Lechner, Alexandra Drakaki, Javier Baena, Caroline A Nebhan, Tarek Haykal, Michael A Morse, Alessio Cortellini, David James Pinato, Alessia Dalla Pria, Evan Thomas Hall, Veli Bakalov, Nathan Bahary, Aarthi Rajkumar, Ankit Mangla, Vishal S Shah, Parminder Singh, Frank Aboubakar Nana, Nerea Lopetegui Lia, Danai Dima, Ryan W Dobbs, Pauline Funchain, Rabia Saleem, Rachel G Woodford, Georgina V Long, Alexander M Menzies, Carlo Genova, Giulia Barletta, Sonam Puri, Vaia Florou, Dame Idossa, Maristella Saponara, Paola Queirolo, Giuseppe Lamberti, Alfredo Addeo, Melissa Bersanelli, Dory Freeman, Wanling Xie, Erin G Reid, Elizabeth Yu Chiao, Elad Sharon, Douglas B Johnson, Ramya Ramaswami, Mark Bower, Brinda Emu, Thomas U Marron, Toni K Choueiri, Lindsey R Baden, Kathryn Lurain, Guru P Sonpavde, Abdul Rafeh Naqash
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sandip Pravin Patel, Megan K D Othus, Young Kwang Chae, Michael J Dennis, Sarah Gordon, David G Mutch, Wolfram E Samlowski, William R Robinson, Elad Sharon, Christopher Ryan, Gabby Lopez, Melissa Plets, Charles David Blanke, Razelle Kurzrock
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tian Zhang, Patrick M Forde, Ryan J Sullivan, Elad Sharon, Elizabeth Barksdale, Wendy Selig, Scot Ebbinghaus, Gina Fusaro, Damla Gunenc, Dena Battle, Robyn Burns, Marc S Hurlbert, Mark Stewart, Michael B Atkins
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designs. Journal for immunotherapy of cancer 11 (5) (2023)
Harriet M Kluger, J Carl Barrett, Justin F Gainor, Omid Hamid, Michael Hurwitz, Theresa LaVallee, Rebecca A Moss, Roberta Zappasodi, Ryan J Sullivan, Hussein A Tawbi, Elad Sharon
Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Journal for immunotherapy of cancer 11 (3) (2023)
Osama E Rahma, Kevin Tyan, Anita Giobbie-Hurder, Andrew S Brohl, Philippe L Bedard, Daniel J Renouf, Elad Sharon, Howard Streicher, Emma Hathaway, Rachel Cunningham, Michael Manos, Mariano Severgnini, Scott Rodig, F Stephen Hodi
Phase IB study of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors. Journal for immunotherapy of cancer 10 (3) (2022)
Amanda N Ruggieri, Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X Chen, Brian M Olson, Chrystal M Paulos, Bassel F El-Rayes, Shishir K Maithel, Nilofer S Azad, Gregory B Lesinski
Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (19) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Kerry L Reynolds, Shaily Arora, Ravikumar Komandur Elayavilli, William C Louv, Teilo H Schaller, Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael L Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma, Elad Sharon
Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data. Journal for immunotherapy of cancer 9 (7) (2022)
Daniel M Girardi, Scot A Niglio, Amir Mortazavi, Rosa Nadal Rios, Primo Lara, Sumanta K Pal, Biren Saraiya, Lisa Cordes, Lisa Ley, Olena Sierra Ortiz, Jacqueline Cadena, Carlos Diaz, Hadi Bagheri, Bernadette Redd, Seth M Steinberg, Rene Costello, Keith S Chan, Min-Jung Lee, Min-Jung Lee, Yunkai Yu, Sandeep Gurram, Heather J Chalfin, Vladimir Valera, William Douglas Figg, Maria J Merino, Antoun Toubaji, Howard Streicher, John J Wright, Elad Sharon, Howard L Parnes, Yang-Min Ning, Donald P Bottaro, Liang Cao, Jane B Trepel, Andrea B Apolo
Cabozantinib plus Nivolumab Phase I Expansion Study in Patients with Metastatic Urothelial Carcinoma Refractory to Immune Checkpoint Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (7) (2022)
Anjali S Advani, Anna B Moseley, Kristen M O'Dwyer, Brent L Wood, Min Fang, Matthew J Wieduwilt, Ibrahim Aldoss, Jae H Park, Rebecca B Klisovic, Maria R Baer, Wendy Stock, Rupali R Bhave, Megan K D Othus, Richard C Harvey, Cheryl L Willman, Mark R Litzow, Richard M Stone, Elad Sharon, Harry P Erba
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Abdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, Mehak Laharwal, Vanessa Hill, Nagabhishek Moka, Shanda R Finnigan, James Murray, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation Program. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (29) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Anjali S Advani, Anna B Moseley, Kristen M O'Dwyer, Brent L Wood, Jae H Park, Matthew J Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab Atallah, Aaron T Gerds, Susan M O'Brien, Jane L Liesveld, Megan Othus, Mark R Litzow, Richard M Stone, Elad Sharon, Harry P Erba
Dasatinib/Prednisone Induction Followed by Blinatumomab/Dasatinib in Ph+ Acute Lymphoblastic Leukemia. Blood advances (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
LeAnne Young, Shanda Finnigan, Howard Streicher, Helen X Chen, James Murray, H Nida Sen, Elad Sharon
Ocular adverse events in PD-1 and PD-L1 inhibitors. Journal for immunotherapy of cancer 9 (7) (2022)
Michael J Wagner, Megan Othus, Sandip P Patel, Chris Ryan, Ashish Sangal, Benjamin Powers, G Thomas Budd, Adrienne I Victor, Chung-Tsen Hsueh, Rashmi Chugh, Suresh Nair, Kirsten M Leu, Mark Agulnik, Elad Sharon, Edward Mayerson, Melissa Plets, Charles Blanke, Howard Streicher, Young Kwang Chae, Razelle Kurzrock
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART). Journal for immunotherapy of cancer 9 (8) (2022)
Fangwen Zou, David Faleck, Anusha Thomas, Jessica Harris, Deepika Satish, Xuemei Wang, Aline Charabaty, Marc S Ernstoff, Isabella C Glitza Oliva, Stephen Hanauer, Jennifer McQuade, Michel Obeid, Amishi Shah, David M Richards, Elad Sharon, Jedd Wolchok, John Thompson, Yinghong Wang
Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study. Journal for immunotherapy of cancer 9 (11) (2022)
Abdul Rafeh Naqash, Douglas B Johnson, Javid J Moslehi, Elad Sharon
Reply to S. Rossi et al and P. Palassin et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Kenneth F Grossmann, Megan Othus, Sapna Pradyuman Patel, Ahmad A Tarhini, Vernon K Sondak, Michael V Knopp, Teresa M Petrella, Thach-Giao Truong, Nikhil I Khushalani, Justine V Cohen, Elizabeth I Buchbinder, Kari L Kendra, Pauline Funchain, Karl D Lewis, Robert M Conry, Bartosz Chmielowski, Ragini R Kudchadkar, Douglas B Johnson, Hongli Li, James Moon, Zeynep Eroglu, Brian Gastman, Magdalena Kovacsovics-Bankowski, Krishna S Gunturu, Scot W Ebbinghaus, Sama Ahsan, Nageatte Ibrahim, Elad Sharon, Larissa A Korde, Joanne M Jeter, Antoni Ribas
Adjuvant pembrolizumab versus interferon alfa-2b or ipilimumab in resected high-risk melanoma. Cancer discovery (2021)
Claire F Friedman, Alexandra Snyder Charen, Qin Zhou, Michael A Carducci, Alexandre Buckley De Meritens, Bradley R Corr, Siqing Fu, Travis J Hollmann, Alexia Iasonos, Jason A Konner, Panagiotis A Konstantinopoulos, Susan C Modesitt, Elad Sharon, Carol Aghajanian, Dmitriy Zamarin
Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer. Journal for immunotherapy of cancer 8 (2) (2021)
Geraldine O'Sullivan Coyne, Shivaani Kummar, James S Hu, Kristen N Ganjoo, Warren A Chow, Khanh T Do, Jennifer Zlott, Ashley Bruns, Lawrence V Rubinstein, Jared C Foster, Lamin Juwara, Robert Meehan, Richard L Piekarz, Howard Streicher, Elad Sharon, Naoko Takebe, Andrea Regier Voth, Donald P Bottaro, Rene Costello, John J Wright, James H Doroshow, Helen X Chen
Clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue Sarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Paul T Nghiem, Shailender Bhatia, Evan J Lipson, William H Sharfman, Ragini R Kudchadkar, Andrew S Brohl, Philip A Friedlander, Adil Daud, Harriet M Kluger, Sunil A Reddy, Brian C Boulmay, Adam Riker, Melissa A Burgess, Brent A Hanks, Thomas Olencki, Kari Kendra, Candice Church, Tomoko Akaike, Nirasha Ramchurren, Michi M Shinohara, Bob Salim, Janis M Taube, Erin Jensen, Mizuho Kalabis, Steven P Fling, Blanca Homet Moreno, Elad Sharon, Martin A Cheever, Suzanne L Topalian
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma. Journal for immunotherapy of cancer 9 (4) (2021)
Naoko Takebe, Abdul Rafeh Naqash, Geraldine O'Sullivan Coyne, Shivaani Kummar, Khanh Do, Ashley Bruns, Lamin Juwara, Jennifer Zlott, Lawrence V Rubinstein, Richard L Piekarz, Elad Sharon, Howard Streicher, Arjun Mittra, Sarah B Miller, Jiuping Ji, Deborah Wilsker, Robert J Kinders, Ralph E Parchment, Li Chen, Ting-Chia Chang, Biswasjit Das, Ganesh Mugundu, James H Doroshow, Helen X Chen
Safety, Antitumor Activity, and Biomarker Analysis in a Phase I Trial of the Once-daily Wee1 Inhibitor Adavosertib (AZD1775) in Patients with Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (14) (2021)
Helen X Chen, Minkyung Song, Holden T Maecker, Sacha Gnjatic, David R Patton, Jiun-Kae Jack Lee, Stacey J Adam, Radim Moravec, Xiaole Shirley Liu, Ethan Cerami, James R Lindsay, Ming Tang, F Stephen Hodi, Catherine J Wu, Ignacio I Wistuba, Gheath Al-Atrash, Chantale Bernatchez, Sean C Bendall, Stephen M Hewitt, Elad Sharon, Howard Streicher, Rebecca A Enos, Melissa D Bowman, Valerie M Tatard-Leitman, Beatriz Sanchez-Espiridion, Srinika Ranasinghe, Mina Pichavant, Diane M Del Valle, Joyce Yu, Sylvie Janssens, Jenny Peterson-Klaus, Cathy Rowe, Gerold Bongers, Robert R Jenq, Chia-Chi Chang, Jeffrey S Abrams, Margaret M Mooney, James H Doroshow, Lyndsay N Harris, Magdalena Thurin
Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (18) (2021)
Sylvia Adams, Megan Othus, Sandip Pravin Patel, Kathy D Miller, Rashmi Chugh, Scott M Schuetze, Mary D Chamberlin, Barbara J Haley, Anna Maria V Storniolo, Mridula P Reddy, Scott A Anderson, Collin T Zimmerman, Anne P O'Dea, Hamid R Mirshahidi, Jordi Rodon Ahnert, Frank J Brescia, Olwen Hahn, Jane M Raymond, David D Biggs, Roisin M Connolly, Elad Sharon, Larissa A Korde, Robert C Gray, Edward Mayerson, Melissa Plets, Charles D Blanke, Young Kwang Chae, Razelle Kurzrock
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609). Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Arjun Mittra, Abdul Rafeh Naqash, James H Murray, Shanda R Finnigan, Joanne Kwak-Kim, Susan Percy Ivy, Helen X Chen, Elad Sharon
Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute. The oncologist 26 (10) (2021)
Arta M Monjazeb, Anita Giobbie-Hurder, Ana Lako, Emily M Thrash, Ryan C Brennick, Katrina Z Kao, Claire Manuszak, Ryan D Gentzler, Anteneh A Tesfaye, Salma K Jabbour, Olatunji B Alese, Osama E Rahma, James M Cleary, Elad Sharon, Harvey J Mamon, May Cho, Howard Streicher, Helen X Chen, Mansoor M Ahmed, Adrian Mariño-Enríquez, Seunghee Kim-Schulze, Sacha Gnjatic, Emanual Maverakis, Alina I Marusina, Alexander A Merleev, Mariano Severgnini, Kathleen L Pfaff, James R Lindsay, Jason L Weirather, Srinika Ranasinghe, Alexander Spektor, Scott J Rodig, Stephen F Hodi, Jonathan D Schoenfeld
A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Harriet M Kluger, Hussein A Tawbi, Maria L Ascierto, Michaela Bowden, Margaret K Callahan, Edward Cha, Helen X Chen, Charles G Drake, David M Feltquate, Robert L Ferris, James L Gulley, Shilpa Gupta, Rachel W Humphrey, Theresa M LaVallee, Dung T Le, Vanessa M Hubbard-Lucey, Vassiliki A Papadimitrakopoulou, Michael A Postow, Eric H Rubin, Elad Sharon, Janis M Taube, Suzanne L Topalian, Roberta Zappasodi, Mario Sznol, Ryan J Sullivan
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce. Journal for immunotherapy of cancer 8 (1) (2021)
Bhanu P Venkatesulu, Scott C Lester, Rodney Cheng-En Hsieh, Vivek Verma, Elad Sharon, Mansoor Ahmed, Krishnan Sunil
Low-Dose Radiation Therapy for COVID-19: Promises and Pitfalls. JNCI cancer spectrum 5 (1) (2020)
Hannah R Wardill, Stephen T Sonis, Nicole M A Blijlevens, Ysabella Z A Van Sebille, Matthew A Ciorba, Erik A H Loeffen, Kin Fong Karis Cheng, Paolo Bossi, Lorraine Porcello, D A Castillo, Elad Sharon, Joanne M Bowen, null null
Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 28 (11) (2020)
Sandip P Patel, Megan Othus, Young Kwang Chae, Francis J Giles, Donna E Hansel, Preet Paul Singh, Annette Fontaine, Manisha H Shah, Anup Kasi Loknath Kumar, Tareq Al Baghdadi, Marc Matrana, Zoran Gatalica, Wolfgang Michael Korn, Jourdain Hayward, Christine McLeod, Helen X Chen, Elad Sharon, Edward Mayerson, Christopher W Ryan, Melissa Plets, Charles D Blanke, Razelle Kurzrock
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (10) (2020)
Daniel L Barber, Ragini R Kudchadkar, Steven P Fling, Tracey A Day, Julie A Vergara, David Ashkin, Jonathan H Cheng, Lisa M Lundgren, Vanessa N Raabe, Colleen S Kraft, Jorge J Nieva, Martin A Cheever, Paul T Nghiem, Elad Sharon
Tuberculosis following PD-1 blockade for cancer immunotherapy. Science translational medicine 11 (475) (2020)
Colleen S Curran, Connie L Sommers, Howard A Young, Katarzyna Bourcier, Marie Mancini, Elad Sharon
Report on the 2018 Cancer, Autoimmunity, and Immunology Conference. Journal of immunology (Baltimore, Md. : 1950) 202 (10) (2019)